According to the recent study the clinical trial supply market is projected to reach an estimated $4.0 billion by 2028 from $2.7 billion in 2023, at a CAGR of 7.7% from 2023 to 2028. Growth in this market is primarily driven by increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.

A more than 150 – page report is developed to understand trends, opportunities and forecast in clinical trial supply market by service (logistics & distribution, storage & retention, packaging, labeling, and blinding, manufacturing, and comparator sourcing), type (small-molecules, biologic drugs, and medical devices), therapeutic area (oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, and blood disorders), end use industry(pharmaceutical & biotechnology companies, contract research organisations, and medical device companies), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Download sample report by clicking on below link https://www.lucintel.com/clinical-trial-supply-market.aspx

“Oncology market is expected to remain the largest segment during the forecast period.”

Based on therapeutic area, the clinical trial supply market is segmented into oncology, CNS and mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, and blood disorders. Lucintel forecasts that the oncology market is expected to remain the largest segment as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.

“Within the clinical trial supply market, the pharmaceutical and bioend use industry companies segment is expected to remain the largest end use industry”

Based on end use industry the pharmaceutical and bioend use industry companies segment is expected to witness the highest growth over the forecast period due to increasing in number of clinical trails being conducted pharmaceutical and biotechnology companies to develop new drugs and treatment that drives the market.

“Asia pacific will dominate the clinical trial supply market in near future”

APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.

Download Brochure of this report by clicking on https://www.lucintel.com/clinical-trial-supply-market.aspx

Major players of clinical trial supply market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, and PRA Health Sciences are among the major clinical trial supply providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/clinical-trial-supply-market.aspx  or helpdesk@lucintel.com